COMMUNIQUÉS West-GlobeNewswire

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23/06/2025
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) [...]
Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank
23/06/2025
CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced [...]
Cidara Announces Proposed Public Offering of Common Stock
23/06/2025
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today [...]
Austin Texas Air Filters Company Camfil Offers Cutting Edge Clean Air Solutions
23/06/2025
Discover Camfil's tailored clean air solutions for Austin's energy sector, for enhanced efficiency, sustainability, and compliance with advanced filtration systems. Austin, TX, June 23, 2025 (GLOBE NEWSWIRE) -- [...]
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)
23/06/2025
LOUISVILLE, Ky., June 23, 2025 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent specialty pharmacy, has been selected as a specialty pharmacy partner by Deciphera Pharmaceuticals, LLC for ROMVIMZA ™ ( [...]
Jushi and Real Housewives Star Stacey Rusch Celebrate Successful Launch of Lifestyle Cannabis Brand ‘Shayo’
23/06/2025
(Photo credit: Andreas Neumann) BOCA RATON, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF) has partnered with entrepreneur, philanthropist, and Real [...]
Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
23/06/2025
SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer, announced today [...]
Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
23/06/2025
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting [...]
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
24/06/2025
How Parkinson’s affects million – and why current treatments are not enough Continuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson’s care Serina’s drug candidate SER-252 is designed to deliver [...]
HepatoBurn 2025: Experts Discuss the Mitochondrial Science Behind Hepato Burn Emerging Weight Support Formula
23/06/2025
HepatoBurn gains momentum in metabolic circles for its mitochondria-driven formula designed to aid liver fat processing and support weight balance. New York City, NY, June 23, 2025 (GLOBE NEWSWIRE) -- In 2025, the [...]
Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities
23/06/2025
Pending a decision from the European Commission, Ozempic ® (once-weekly semaglutide) will have the broadest approved label in the glucagon-like peptide-1 receptor agonist (GLP-1 RA) class, demonstrating improvements in [...]
Bioma Probiotics Officially Launches: A Revolutionary Step Toward Total Gut Health
23/06/2025
Bioma Probiotics combines prebiotics, probiotics & postbiotics to support digestion, reduce bloating, and boost mood naturally. new york City, NY, June 23, 2025 (GLOBE NEWSWIRE) -- Bioma Probiotics In a bold move to [...]
SickKids staff to join hospital workers across Ontario as members of the Healthcare of Ontario Pension Plan (HOOPP)
23/06/2025
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) and The Hospital for Sick Children (SickKids) are pleased to announce that SickKids employees will become members of HOOPP’s [...]
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
23/06/2025
Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression Six-Month Patient Follow-up Results Demonstrate that Sana’s [...]
Simple Divorce Releases New Study on Impact of Economic Factors on Divorce Rates in Ontario
23/06/2025
Toronto, Ontario, June 23, 2025 (GLOBE NEWSWIRE) -- A recent study from Simple Divorce has uncovered a compelling connection between financial stress and increasing divorce rates across Ontario. The findings shine a [...]
Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
23/06/2025
Vancouver, Canada, June 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
23/06/2025
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) [...]
Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025
23/06/2025
Patients treated with CX11 (also designated as VCT220) achieved a 9.7% and 9.4% decrease in body weight from baseline after 16 weeks (p≤0.001) in the 160 mg fast and slow titration cohorts, respectively. Results suggest [...]
Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA)
23/06/2025
Oral presentation highlighted the post-hoc analysis during the “Interventions to Prevent Hypoglycemia: Bench to Bedside” session Treatment with sotagliflozin resulted in no increased risk and a reduction in hypoglycemia [...]

Pages